| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |